Spectrum of Neuro-AIDS Disorders

covers new developments in the field of Neuro-AIDS in the HAART (highly-active antiretroviral therapy) era; presents specific information on special populations affected by neuro-AIDS disorders, including women, minorities, children, and the elderly; explores medicolegal issues, including end-of-life issues specific to neuro-AIDS patients; provides basic pathophysiology updates on topics such as viral evolution, chemokines, cerebrospinal fluid biomarkers, cell cycle proteins, and vaccines and neuro-AIDS; features new 2005 proposed diagnostic criteria for HIV-1-associated cognitive disorders.